estriol cream: 1 g intravaginal estriol via applicator twice a week before going to bed for 4 weeks
Study summary
The aim of the study is to evaluate the effects of local estriol treatment applied before vaginal repair surgery on steroid receptors, inflammatory cell response, vascular, connective and nervous tissues in the vagina, and its effects on early postoperative period pelvic floor functions, satisfaction with the surgery and vaginal health.
Eligibility
Sex
FEMALE
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
-Postmenopausal women with a diagnosis of pelvic organ prolapse and an indication for vaginal repair surgery including colporrhaphy anterior and/or posterior surgery
Exclusion Criteria:
* Psychiatric and neurological disease that causes disability in mental and motor functions
* receiving systemic/local hormone replacement therapy in the last three months
* applying vulvar/local steroids for any reason within the last three months
* receiving treatment for pelvic and/or lower genital tract infection in the last three months
* history of malignancy
* previous vaginal repair surgery with/without mesh
Primary outcome measure(s)
Morphological examinations of vaginal tissues obtained after surgery from the study and control groups — 4 weeks after starting local estriol treatment 1x0.5 cm tissue samples, made by Ankara University Faculty of Medicine, Department of Medical Pathology, will be taken from the vaginal tissues obtained after surgery from the study and control groups. After paraffin blocking, Epithelial thickness will be evaluated during routine histopathological evaluation with H.E staining. Epithelial thickness will be evaluated in micrometers
Immunohistochemical examinations of vaginal tissues obtained after surgery from the study and control groups — 4 weeks after starting local estriol treatment Sections obtained from the blocks will be sectioned with 6 samples per glass, and steroid receptors (ER, PR, AR), CD3/CD20/CD68/CD4/CD8, CD34 and S100 will be stained with the Ventana automatic staining device and as secondary antibodies. (A total of 60 immunohistochemical tests will be performed in 6 glasses of 10 antibodies to be studied). With these dyes, the presence and density of CD3/CD20/CD68/CD4/CD8 and inflammatory cells in the epithelial and subepithelial tissue and the type distribution of immune cells will be determined. Vascular endothelial density will be evaluated with CD34 and nerve fiber density will be evaluated with S100.
Morphological examinations of vaginal tissues obtained after surgery from the study and control groups — 4 weeks after starting local estriol treatment The alignment and maturation of vaginal epithelial squamous cells will be evaluated during routine histopathological evaluation. Alignment and maturation of squamous cells will be evaluated as a percentage.
Morphological examinations of vaginal tissues obtained after surgery from the study and control groups — 4 weeks after starting local estriol treatment Connective tissue changes in the vaginal subepithelial area will be evaluated during routine histopathological evaluation. Connective tissue change in the subepithelial area will be evaluated as a percentage.
Morphological examinations of vaginal tissues obtained after surgery from the study and control groups — 4 weeks after starting local estriol treatment Distribution of vaginal vascular structures will be evaluated during routine histopathological evaluation. Distribution of vascular structures will be evaluated as a percentage.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.